| |
# Patients analysed |
# Patients with MD in control |
# Patients with MD in mepilex |
Total # patients with MD |
% Patients with MD |
| DUN |
28 |
0 |
0 |
4 |
14 |
| WGN |
23 |
4 |
4 |
15 |
65 |
| ARO |
10 |
2* |
2 |
3 |
30 |
| PLM |
13 |
8** |
5 |
13 |
100 |
| Total |
74 |
14 |
11 |
35 |
47 |
| % total |
100 |
19 |
15 |
47 |
|
*Both patients developed MD in control and Mepilex patches. **Five of the eight patients developed MD in control and Mepilex patches. |
